Hangzhou AGS MedTech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005ZF0
CNY
61.33
0.18 (0.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
156.90
173.83
128.60
209.38
161.20
150.81
111.56
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
156.90
173.83
128.60
209.38
161.20
150.81
111.56
Raw Material Cost
45.34
54.55
39.85
59.89
45.37
44.65
32.53
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.02
0.03
0.03
0.04
0.00
0.00
0.01
Selling and Distribution Expenses
37.35
30.96
21.86
28.89
24.89
25.82
23.14
Other Expenses
2.27
2.11
1.26
1.75
1.54
1.42
1.13
Total Expenditure (Excl Depreciation)
105.39
106.64
74.37
106.36
85.64
84.64
66.97
Operating Profit (PBDIT) excl Other Income
51.5
67.2
54.2
103
75.6
66.2
44.6
Other Income
10.54
17.14
12.10
13.48
10.10
18.24
18.21
Operating Profit (PBDIT)
60.23
85.49
69.94
113.90
87.71
86.48
63.53
Interest
0.02
0.03
0.03
0.04
0.00
0.00
0.01
Exceptional Items
-0.34
1.01
0.00
2.08
0.00
0.00
0.00
Gross Profit (PBDT)
111.55
119.28
88.75
149.48
115.83
106.16
79.03
Depreciation
0.00
3.63
3.63
2.57
2.57
2.45
2.45
Profit Before Tax
59.86
82.84
66.29
113.37
85.13
84.03
61.07
Tax
8.87
13.07
10.04
17.42
12.13
12.36
8.29
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.99
69.77
56.25
95.94
73.00
71.67
52.78
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.99
69.77
56.25
95.94
73.00
71.67
52.78
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.99
69.77
56.25
95.94
73.00
71.67
52.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,488.11
2,427.02
2,454.10
2,397.11
2,295.51
2,220.98
2,242.06
Earnings per share (EPS)
0.63
0.87
0.7
1.19
0.91
0.89
0.65
Diluted Earnings per share
0.63
0.87
0.7
1.19
0.91
0.89
0.65
Operating Profit Margin (Excl OI)
31.67%
37.23%
42.16%
46.73%
46.55%
43.62%
38.42%
Gross Profit Margin
38.15%
49.74%
54.36%
55.37%
54.41%
57.34%
56.94%
PAT Margin
32.5%
40.14%
43.74%
45.82%
45.28%
47.52%
47.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is -2.67% vs 14.90% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is -30.14% vs 13.35% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -35.95% vs 22.40% in Sep 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of Hangzhou AGS MedTech Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
156.90
0
156.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
156.90
0
156.90
Raw Material Cost
45.34
0
45.34
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.02
0
0.02
Selling and Distribution Expenses
37.35
0
37.35
Other Expenses
2.27
0.00
2.27
Total Expenditure (Excl Depreciation)
105.39
0
105.39
Operating Profit (PBDIT) excl Other Income
51.50
0.00
51.50
Other Income
10.54
0
10.54
Operating Profit (PBDIT)
60.23
0
60.23
Interest
0.02
0
0.02
Exceptional Items
-0.34
0
-0.34
Gross Profit (PBDT)
111.55
0
111.55
Depreciation
0.00
0
0.00
Profit Before Tax
59.86
0
59.86
Tax
8.87
0
8.87
Provisions and contingencies
0
0
0.00
Profit After Tax
50.99
0
50.99
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
50.99
0
50.99
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.99
0
50.99
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,488.11
0
2,488.11
Earnings per share (EPS)
0.63
0
0.63
Diluted Earnings per share
0.63
0
0.63
Operating Profit Margin (Excl OI)
31.67%
0%
0.00
31.67%
Gross Profit Margin
38.15%
0%
0.00
38.15%
PAT Margin
32.50%
0%
0.00
32.50%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 15.69 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -9.72% vs 35.15% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -2.67% vs 14.90% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.10 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -26.93% vs 24.20% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -30.14% vs 13.35% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.97 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -27.23% vs 18.17% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -35.95% vs 22.40% in Sep 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.67%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024